Comment on: New Influenza Drug Brings New Promise

      Editor’s Note

      For the treatment of influenza, a full course of therapy ranges in price and is approximately the following, based on recent pricing (as of April 5, 2019). When comparing the prices of these agents, note that they will vary depending on dosage form, age, weight, renal function, and other factors for the patient.
      • Baloxavir marboxil (Xofluza), $156
      • Oseltamivir (generic Tamiflu, 30 and 75 mg capsules), $52
      • Zanamivir (Relenza), $65
      • Peramivir (Rapivab), $317
      Many factors need to be considered before choosing the best therapy for an individual patient, but price alone should never be the reason for the final decision.

      Linked Article

      • New Influenza Drug Brings New Promise
        Caring for the AgesVol. 20Issue 4
        • Preview
          Currently the Centers for Disease Control and Prevention (CDC)recommend that everyone 6 months of age and older receive a flu vaccine every season. Because the influenza virus replicates and mutates frequently, the vaccine often does not contain all the strains that people are infected with.
        • Full-Text
        • PDF